We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+12.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$50B
AUM Growth
+$1.17B
(+2.4%)
Cap. Flow
-$2.18B
Cap. Flow
% of AUM
-4.37%
Top 10 Holdings %
Top 10 Hldgs %
19.12%
Holding
2,694
New
394
Increased
928
Reduced
982
Closed
383
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$629M |
| 2 |
Walmart Inc
WMT
|
+$511M |
| 3 |
Meta Platforms (Facebook)
META
|
+$480M |
| 4 |
Progressive
PGR
|
+$339M |
| 5 |
Intuitive Surgical
ISRG
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$620M |
| 2 |
Snowflake
SNOW
|
+$450M |
| 3 |
Cencora
COR
|
+$403M |
| 4 |
Carvana
CVNA
|
+$320M |
| 5 |
MSCI
MSCI
|
+$318M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Financials | 17.22% |
| 3 | Consumer Discretionary | 12.2% |
| 4 | Healthcare | 11.63% |
| 5 | Industrials | 11.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
XBiotech
XBIT
$69.2M
| $43.4K | ﹤0.01% |
16,300
| – | – |
|
2277
Kopin
KOPN
$654M
| $41.3K | ﹤0.01% |
+17,000
| New | +$34.7K |
|
|
EPIX
2278
DELISTED
ESSA Pharma
EPIX
| $41K | ﹤0.01% |
214,800
-46,000
| -18% | -$55.1K |
|
|
BHR
2279
Braemar Hotels & Resorts
BHR
$160M
| $40.1K | ﹤0.01% |
14,700
-2,800
| -16% | -$7.08K |
|
|
CRDL
2280
Cardiol Therapeutics
CRDL
$138M
| $34.9K | ﹤0.01% |
+32,608
| New | +$39.6K |
|
2281
Mercer International
MERC
$45.6M
| $33.4K | ﹤0.01% |
11,600
-158,741
| -93% | -$523K |
|
|
EONR
2282
EON Resources
EONR
$24M
| $32.8K | ﹤0.01% |
+67,315
| New | +$24.5K |
|
2283
Butterfly Network
BFLY
$1.88B
| $32.6K | ﹤0.01% |
16,900
-127,900
| -88% | -$217K |
|
|
CGC
2284
Canopy Growth
CGC
$377M
| $31.8K | ﹤0.01% |
+21,797
| New | +$28.3K |
|
|
NFGC
2285
New Found Gold
NFGC
$542M
| $31.8K | ﹤0.01% |
+13,400
| New | +$23.6K |
|
2286
NN Inc
NNBR
$261M
| $31.5K | ﹤0.01% |
+15,300
| New | +$34.3K |
|
2287
Innoviz Technologies
INVZ
$99.5M
| $31.2K | ﹤0.01% |
+15,300
| New | +$26.1K |
|
2288
Kaltura
KLTR
$217M
| $30.7K | ﹤0.01% |
21,300
-3,800
| -15% | -$6.41K |
|
2289
GEE Group
JOB
$23.1M
| $28.5K | ﹤0.01% |
137,800
-1,100
| -0.8% | -$224 |
|
2290
Twin Vee PowerCats
VEEE
$8.51M
| $27.4K | ﹤0.01% |
+270
| New | +$22.9K |
|
2291
DocGo
DCGO
$62.4M
| $25.6K | ﹤0.01% |
+18,800
| New | +$28.5K |
|
2292
Xilio Therapeutics
XLO
$60.2M
| $25K | ﹤0.01% |
+2,121
| New | +$21.2K |
|
|
NOTV
2293
DELISTED
Inotiv
NOTV
| $24.4K | ﹤0.01% |
16,800
-300
| -2% | -$536 |
|
2294
ECARX Holdings
ECX
$424M
| $24K | ﹤0.01% |
+11,923
| New | +$21.1K |
|
2295
Protalix BioTherapeutics
PLX
$188M
| $22.9K | ﹤0.01% |
+10,300
| New | +$16.8K |
|
2296
Traeger
COOK
$164M
| $22.2K | ﹤0.01% |
+364
| New | +$27.9K |
|
|
MURA
2297
DELISTED
Mural Oncology
MURA
| $21.1K | ﹤0.01% |
+10,200
| New | +$21.9K |
|
2298
Montauk Renewables
MNTK
$259M
| $20.7K | ﹤0.01% |
+10,300
| New | +$22.1K |
|
2299
Coherus Oncology
CHRS
$222M
| $20.5K | ﹤0.01% |
+12,500
| New | +$13.9K |
|
2300
Lineage Cell Therapeutics
LCTX
$267M
| $19.8K | ﹤0.01% |
11,700
-2,800
| -19% | -$3.31K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, Two Sigma Advisers held 2,694 positions worth $50B, up 2.4% from $48.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Two Sigma Advisers withdrew a net $2.18B in Q3 2025, closing 383 positions and reducing 982 holdings. Its most notable exit was Aon, an estimated $258M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Two Sigma Advisers opened a new position in TJX Companies worth $209M.
- Two Sigma Advisers's largest Q3 2025 buy was TJX Companies: 1,447,098 shares worth $209M.
- Two Sigma Advisers added most to JPMorgan Chase in Q3 2025, an estimated $629M increase.
- Two Sigma Advisers's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $620M.
- Two Sigma Advisers fully exited Aon in Q3 2025, selling an estimated $258M.
- Two Sigma Advisers's ten largest holdings make up 19% of its $50B portfolio in Q3 2025.
- Two Sigma Advisers opened 394 new positions and closed 383 in Q3 2025.
- Two Sigma Advisers's portfolio value rose 2.4% quarter-over-quarter to $50B.
Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.